Prosecution Insights
Last updated: April 19, 2026

Examiner: OYEYEMI, OLAYINKA A

Tech Center 1600 • Art Units: 1637 1681

This examiner grants 60% of resolved cases

Performance Statistics

60.3%
Allow Rate
At TC average
478
Total Applications
+46.6%
Interview Lift
1344
Avg Prosecution Days
Based on 456 resolved cases, 2023–2026

Rejection Statute Breakdown

11.9%
§101 Eligibility
13.8%
§102 Novelty
32.7%
§103 Obviousness
29.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17518129 METHODS AND SYSTEMS FOR DETECTING PATHOGENIC MICROBES IN A PATIENT Non-Final OA ILLUMINA, INC.
18053785 mecA GENE AMPLIFICATION PRIMER PAIR, mecA GENE DETECTION KIT AND mecA GENE DETECTION METHOD Non-Final OA MITSUI CHEMICALS, INC.
17708005 METHOD OF DIAGNOSING AND MONITORING SUBSTANCE ADDICTION OR BEHAVIORAL ADDICTION USING C-KIT BIOMARKER Non-Final OA Wuhan University
17677600 Combinatorial Microarray Assay for Detecting and Genotyping SARS-CoV-2 Non-Final OA University of Maryland, Baltimore
17361829 DETECTION OF TARGET NUCLEIC ACID AND VARIANTS Non-Final OA SAGA DIAGNOSTICS AB
18038248 UNIVERSAL PRIMERS FOR RAPID BACTERIAL GENOME DETECTION Non-Final OA Day Zero Diagnostics, Inc.
17642166 NUCLEIC ACID DETECTION METHOD BY REAL-TIME PCR Non-Final OA NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT
17692236 PRIMER SET FOR DETECTING FOOD POISONING BACTERIA BY USING NEXT-GENERATION SEQUENCING METHOD AND METHOD FOR DETECTING FOOD POISONING BACTERIA BY USING THE PRIMER SET Final Rejection Korean Ministry of Food and Drug Safety
17456204 METHODS, COMPOSITIONS, KITS, AND USES FOR ANALYSIS OF NUCLEIC ACIDS COMPRISING REPEATING A/T-RICH SEGMENTS Final Rejection Asuragen, Inc.
17611545 NON-CODING RNA FOR SUBTYPING OF BLADDER CANCER Final Rejection Erasmus University Medical Center
17512713 METHOD FOR IDENTIFICATION OF URINE DRUG TESTING SAMPLE Non-Final OA ID Match, LLC
17226688 STRAND DISPLACEMENT STOP (SDS) LIGATION Non-Final OA LEXOGEN GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month